adcetris 50 mg pd. conc. for i.v. inf
ادسيتريس 50مجم محلول وريد
brentuximab vedotinThe published official price. Pharmacies may differ slightly.
- Strength
- 50 mg
- Form
- bottle
- Manufacturer
- pierre - fabre france > takeda
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
CD30-directed antineoplastic agent used for classical Hodgkin lymphoma and certain CD30-positive lymphomas.
Do not use if
Concomitant use with bleomycin due to increased pulmonary toxicity. Hypersensitivity to the product.
Side effects
Peripheral neuropathy, infusion reactions, hematologic toxicity, infections, nausea, and fatigue may occur.
Warnings
Serious infections, progressive multifocal leukoencephalopathy, neuropathy, and infusion reactions may occur. Close monitoring is required.
How it works
Antibody-drug conjugate targeting CD30-expressing cells and delivering a microtubule-disrupting cytotoxic agent.
Storage
Store and handle according to manufacturer instructions. Protect the lyophilized product from inappropriate conditions.